Abstract
Chemokines are involved in a number of pathological processes, and therefore represent important targets. However, it has also become apparent that chemokines have exciting therapeutic applications in inflammatory, infectious and cancer-related diseases. The following review will highlight the application of novel therapies including viral-encoded, recombinant, and genetically engineered chemokines to a number of diseases or disorders. Advances in the application of novel chemokine delivery procedures both at the research bench and the clinical bedside will also be discussed. Overall, the utilization of chemokines to prevent and treat disease has tremendous potential.
Keywords: Chemokomes, chemoattractant proteins MCP, rantes, macrophage Inflammatory, Glu Leu Arg, Oncogene, monokine, interferon gamma, Viral, Kaposi sarcoma associated herpesvirus, T Cell, Dendritic cell movement, EB11 ligand chemokine, immune responses, Pseudomonas aeruginosa, Salmonella typhimurium, ELR CXC, Liver Regeneration, Lymphoid tissue, Wound Healing, cancer, HIV infection, Sepsis, Renal glomerulonephritis, Mycobacterium, Pulmonary granulomatous
Current Pharmaceutical Design
Title: Therapeutic Use of Chemokines
Volume: 6 Issue: 6
Author(s): Cory M. Hogaboam, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew L. Steinhauser, Kate Blease, Nicholas W. Lukacs and Steven L. Kunkel
Affiliation:
Keywords: Chemokomes, chemoattractant proteins MCP, rantes, macrophage Inflammatory, Glu Leu Arg, Oncogene, monokine, interferon gamma, Viral, Kaposi sarcoma associated herpesvirus, T Cell, Dendritic cell movement, EB11 ligand chemokine, immune responses, Pseudomonas aeruginosa, Salmonella typhimurium, ELR CXC, Liver Regeneration, Lymphoid tissue, Wound Healing, cancer, HIV infection, Sepsis, Renal glomerulonephritis, Mycobacterium, Pulmonary granulomatous
Abstract: Chemokines are involved in a number of pathological processes, and therefore represent important targets. However, it has also become apparent that chemokines have exciting therapeutic applications in inflammatory, infectious and cancer-related diseases. The following review will highlight the application of novel therapies including viral-encoded, recombinant, and genetically engineered chemokines to a number of diseases or disorders. Advances in the application of novel chemokine delivery procedures both at the research bench and the clinical bedside will also be discussed. Overall, the utilization of chemokines to prevent and treat disease has tremendous potential.
Export Options
About this article
Cite this article as:
Hogaboam M. Cory, Bone-Larson Cynthia, Matsukawa Akihiro, Steinhauser L. Matthew, Blease Kate, Lukacs W. Nicholas and Kunkel L. Steven, Therapeutic Use of Chemokines, Current Pharmaceutical Design 2000; 6 (6) . https://dx.doi.org/10.2174/1381612003400605
DOI https://dx.doi.org/10.2174/1381612003400605 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development
Current Cancer Drug Targets Phenanthrene Dimers: Promising Source of Biologically Active Molecules
Current Topics in Medicinal Chemistry Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy
Mini-Reviews in Medicinal Chemistry Update Clinical Application of Diffusion Tensor Imaging
Current Medical Imaging Role of Nanomedicine in Treatment of Brain Cancer
Current Nanomedicine Combination Treatment of Glioblastoma by Low-Dose Radiation and Genistein
Current Radiopharmaceuticals An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
Current Proteomics Comparative Genomic Hybridization: A Valuable Tool for Genome-Scale Analysis of Rodent Cancer Models
Current Genomics Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Current Gene Therapy Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion
Recent Patents on Anti-Cancer Drug Discovery Human Galectin-3 Selective and High Affinity Inhibitors. Present State and Future Perspectives
Current Medicinal Chemistry Nitroimidazole Radiopharmaceuticals in Bioimaging: Part I: Synthesis and Imaging Applications
Current Radiopharmaceuticals CXCR4 Receptor as a Promising Target for Oncolytic Drugs
Mini-Reviews in Medicinal Chemistry The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases
CNS & Neurological Disorders - Drug Targets Glucose Transporters Regulation on Ischemic Brain: Possible Role as Therapeutic Target
Central Nervous System Agents in Medicinal Chemistry The Tumor Suppressor Role of the Ras Association Domain Family 10
Anti-Cancer Agents in Medicinal Chemistry Competition Between Tumor and Mononuclear Phagocyte System Causing the Low Tumor Distribution of Nanoparticles and Strategies to Improve Tumor Accumulation
Current Drug Delivery Cancer Stem Cells in Prostate Cancer Chemoresistance
Current Cancer Drug Targets Chidamide Inhibits Cell Proliferation via the PI3K/AKT Pathway in K562 Cells Based on Network Pharmacology and Experimental Validation
Current Pharmaceutical Design